METFORMIN Side Effects

6538856-9 | Abdominal Pain, Colonic Stenosis, Diarrhoea, Duodenal Ulcer, Gastritis, Haematemesis, Haemoglobin Decreased, Hepatic Steatosis, Irritable Bowel Syndrome
on Dec 18, 2009 Female patient from UNITED KINGDOM , 42 years of age, was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), colonic stenosis, diarrhoea, duodenal ulcer, gastritis, haematemesis, haemoglobin decreased, hepatic steatosis, irritable bowel syndrome (What is irritable bowel syndrome?). Metformin dosage: 500mg, Tid,. During the same period patient was treated with DICLOFENAC SODIUM (75mg, Bid,) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), NORTRIPTYLINE (10mg - Daily - Oral) (View Nortriptyline Review and Nortriptyline Label ), RIZATRIPTAN BENZOATE (10mg) (View Rizatriptan Benzoate Review and Rizatriptan Benzoate Label ), TEMAZEPAM (10mg - Daily -) (View Temazepam Review and Temazepam Label ), CO PROXAMOL (DI GESIC) (View Co-proxamol (di-gesic) Review and Co-proxamol (di-gesic) Label ). Patient was hospitalized.

6530594-1 | Renal Impairment
Patient was taking Metformin (View Usage). Patient had the following side effects: renal impairment on Dec 30, 2009 from AUSTRIA Additional patient health information: Male patient , 63 years of age, weighting 231.5 lb, was diagnosed with urethral cancer, urinary tract infection staphylococcal, hypertension and. Metformin dosage: 850 Mg, Qd. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), PARACETAMOL (500 Mg, Tid) (View Paracetamol Review and Paracetamol Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (Unk) (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), ESOMEPRAZOLE SODIUM (NEXIUM) (40 Mg, Bid) (View Esomeprazole Sodium (nexium) Review and Esomeprazole Sodium (nexium) Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6529458-9 | Dysarthria, Gait Disturbance, Myoclonus, Nuclear Magnetic Resonance Imaging Brain Abnormal
Adverse event was reported on Dec 16, 2009 by a Male patient taking Metformin (View Usage) (Dosage: 850mg - Daily) . Location: , 51 years of age, After Metformin was administered, patient had the following side effects: dysarthria, gait disturbance, myoclonus, nuclear magnetic resonance imaging brain abnormal. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WATER SOLUBLE VITAMIN COMPLEX (View Water-soluble Vitamin Complex Review and Water-soluble Vitamin Complex Label ). Patient was hospitalized.

6529443-7 | Condition Aggravated, Decreased Appetite, Depression, Psychomotor Hyperactivity, Suicidal Ideation
on Dec 16, 2009 Female patient from , 48 years of age, was diagnosed with diabetes mellitus, type 2 diabetes mellitus, depression (What is depression?) and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, decreased appetite, depression (What is depression?), psychomotor hyperactivity, suicidal ideation. Metformin dosage: Oral. During the same period patient was treated with XANAX (Oral) (View Xanax Review and Xanax Label ), BYETTA (5 Mcg - Subcutaneous) (View Byetta Review and Byetta Label ), PROZAC (Oral) (View Prozac Review and Prozac Label ). Patient was hospitalized.


6529366-3 | Petechiae, Rash Pruritic, Urticaria
on Dec 24, 2009 Female patient from UNITED KINGDOM , 50 years of age, weighting 242.5 lb, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). Patient had the following side effects: petechiae, rash pruritic, urticaria. Metformin dosage: 500mg, Oral. During the same period patient was treated with FERROUS FUMARTE (View Ferrous Fumarte Review and Ferrous Fumarte Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6529345-6 | Agitation, Coma Scale Abnormal, Mechanical Ventilation, Neutrophil Count Increased, Overdose, White Blood Cell Count Increased
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: agitation, coma scale abnormal, mechanical ventilation, neutrophil count increased, overdose, white blood cell count increased on Dec 24, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, was diagnosed with type 2 diabetes mellitus, blood cholesterol increased, depression (What is depression?), schizophrenia, hypertension, constipation (What is constipation?) and. Metformin dosage: 500mg, Tid, Oral. During the same period patient was treated with SIMVASTATIN (40mg, Oral) (View Simvastatin Review and Simvastatin Label ), CLOMIPRAMINE (200mg, Qd, Oral) (View Clomipramine Review and Clomipramine Label ), CLOZARIL (600mg, Qd, Oral; 600mg, Qd, Oral) (View Clozaril Review and Clozaril Label ), HYOSCINE HBR HYT (View Hyoscine Hbr Hyt Review and Hyoscine Hbr Hyt Label ), LISINOPRIL (5mg, Qd, Oral) (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), *SENNA (Oral) (View *senna Review and *senna Label ). Patient was hospitalized.

6528949-4 | Cerebrovascular Accident, Fall, Myelopathy, Vitamin B12 Deficiency, Weight Decreased
Adverse event was reported on Dec 01, 2009 by a Male patient taking Metformin (View Usage) (Dosage: 2g, Oral) was diagnosed with type 2 diabetes mellitus and. Location: UNITED KINGDOM , 68 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, fall (What is fall?), myelopathy, vitamin b12 deficiency, weight decreased. During the same period patient was treated with GLIBENCLAMIDE (Oral) (View Glibenclamide Review and Glibenclamide Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6504816-7 | Dehydration, Diarrhoea, Haemodialysis, Hypotension, Hypoxia, Lactic Acidosis, Pulmonary Oedema, Renal Failure Acute, Vomiting
on Nov 06, 2009 Female patient from UNITED KINGDOM , 49 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient had the following side effects: dehydration, diarrhoea, haemodialysis, hypotension, hypoxia, lactic acidosis, pulmonary oedema, renal failure acute, vomiting. Metformin dosage: Oral. During the same period patient was treated with LOSARTAN (View Losartan Review and Losartan Label ), NSAIDS (View Nsaids Review and Nsaids Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ). Patient was hospitalized.

6496568-4 | Alcohol Use, Blood Pressure Diastolic Decreased, Chest X-ray Abnormal, Dehydration, Fall, Hypoglycaemic Coma, Hypothermia, Lactic Acidosis, Lower Respiratory Tract Infection
on Nov 25, 2009 Female patient from UNITED KINGDOM , 71 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: alcohol use, blood pressure diastolic decreased, chest x-ray abnormal, dehydration, fall (What is fall?), hypoglycaemic coma, hypothermia (What is hypothermia?), lactic acidosis, lower respiratory tract infection. Metformin dosage: 1 Gm, Bid. During the same period patient was treated with GLICLAZIDE (80 Mg, Bid) (View Gliclazide Review and Gliclazide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

6467535-1 | Coma, Dehydration, Hypoglycaemia, Hypothermia, Lactic Acidosis, Lower Respiratory Tract Infection, Renal Cyst, Renal Failure Acute, Tachypnoea
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: coma, dehydration, hypoglycaemia, hypothermia (What is hypothermia?), lactic acidosis, lower respiratory tract infection, renal cyst, renal failure acute, tachypnoea on Nov 04, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 71 years of age, was diagnosed with diabetes mellitus and. Metformin dosage: 1g, Bid. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), GLICLAZIDE (80 Mg - Bid) (View Gliclazide Review and Gliclazide Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6428952-9 | Asthenia, Decreased Appetite, Nausea
Adverse event was reported on Oct 22, 2009 by a Male patient taking Metformin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 182.0 lb, Patient had the following side effects: asthenia, decreased appetite, nausea (What is nausea?). During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), LOSARTAN (View Losartan Review and Losartan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6419386-1 | Idiopathic Urticaria, Viral Rash
on Oct 05, 2009 Female patient from FRANCE , 71 years of age, was diagnosed with diabetes mellitus, infection prophylaxis and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: idiopathic urticaria, viral rash. Metformin dosage: 500mg, Tid, Oral. During the same period patient was treated with AMLODIPINE (10mg, Daily, Oral) (View Amlodipine Review and Amlodipine Label ), SOLU MEDROL (- One Dose) (View Solu-medrol Review and Solu-medrol Label ), BETADINE (- One Dose - Topical) (View Betadine Review and Betadine Label ), ISOPTIN (- One Dose -) (View Isoptin Review and Isoptin Label ), LOVENOX (- One Dose - Sq) (View Lovenox Review and Lovenox Label ), ISOSORBIDE DINITRATE (- One Dose -) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), REPAGLINIDE (1.5 Mg - Daily - Oral) (View Repaglinide Review and Repaglinide Label ), ASPIRIN (160mg - Daily - Oral) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6407420-4 | Amnesia, Balance Disorder, Dementia, Feeling Abnormal
on Oct 13, 2009 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with transient ischaemic attack, vascular dementia and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, balance disorder, dementia (What is dementia?), feeling abnormal. Metformin dosage: . During the same period patient was treated with FLOMAX (View Flomax Review and Flomax Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6386709-1 | Anaemia, Malignant Neoplasm Progression, Melaena, Rectal Haemorrhage, Sepsis
Patient was taking Metformin (View Usage). Patient had the following side effects: anaemia, malignant neoplasm progression, melaena, rectal haemorrhage, sepsis (What is sepsis?) on Sep 23, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 71 years of age, . Metformin dosage: . Patient was hospitalized.

6315830-9 | Lactic Acidosis
Adverse event was reported on Aug 06, 2009 by a Female patient taking Metformin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypoglycaemia and. Location: NETHERLANDS , 62 years of age, After Metformin was administered, patient had the following side effects: lactic acidosis. During the same period patient was treated with GLUCOSE (View Glucose Review and Glucose Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ). Patient was hospitalized.

6312728-7 | Lactic Acidosis
on Aug 05, 2009 Female patient from NETHERLANDS , 62 years of age, was diagnosed with type 2 diabetes mellitus, hypoglycaemia and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis. Metformin dosage: . During the same period patient was treated with GLUCOSE (View Glucose Review and Glucose Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ). Patient was hospitalized.

6305804-6 |
on Jul 31, 2009 Female patient from UNITED KINGDOM , 49 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). . Metformin dosage: 2 G, Unk. During the same period patient was treated with SOLIAN (600 Mg, Unk) (View Solian Review and Solian Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), INSULIN (View Insulin Review and Insulin Label ), NULYTELY (View Nulytely Review and Nulytely Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), SENNA (View Senna Review and Senna Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6299199-4 | Epstein-barr Virus Antibody Positive, Hodgkin's Disease, Onychomycosis, Pyrexia, Tooth Abscess, Weight Increased
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: epstein-barr virus antibody positive, hodgkin's disease (What is hodgkin's disease?), onychomycosis, pyrexia, tooth abscess, weight increased on Jul 28, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, was diagnosed with diabetes mellitus, blood cholesterol increased and. Metformin dosage: Oral. During the same period patient was treated with SIMVASTATIN (Oral) (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6298997-0 | Hepatitis Acute
Adverse event was reported on Jul 21, 2009 by a Female patient taking Metformin (View Usage) (Dosage: 500mg, Oral) was diagnosed with glucose tolerance impaired and. Location: UNITED KINGDOM , 61 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: hepatitis acute. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6298188-3 | Hypoglycaemia
on Jul 22, 2009 Male patient from UNITED KINGDOM , 68 years of age, was treated with Metformin (View Usage). Patient had the following side effects: hypoglycaemia. Metformin dosage: .

6295408-6 | Epstein-barr Virus Associated Lymphoproliferative Disorder, Onychomycosis, Pyrexia, Tooth Abscess, Weight Increased
on Jul 16, 2009 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with diabetes mellitus, blood cholesterol increased, fungal infection (What is fungal infection?), analgesia, psoriatic arthropathy, erectile dysfunction (What is erectile dysfunction?) and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: epstein-barr virus associated lymphoproliferative disorder, onychomycosis, pyrexia, tooth abscess, weight increased. Metformin dosage: Oral. During the same period patient was treated with SIMVASTATIN (Oral) (View Simvastatin Review and Simvastatin Label ), TERBINAFINE (Oral) (View Terbinafine Review and Terbinafine Label ), ACETAMINOPHEN W/ CODEINE (2 - Oral) (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), HUMIRA (40mg - Every Other Week - Subq) (View Humira Review and Humira Label ), SILDENAFIL CITRATE (25mg) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6289385-1 | Hypoglycaemia
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Jul 22, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 68 years of age, . Metformin dosage: 500 Mg, Unk.

6289384-X | Hepatitis Acute
Adverse event was reported on Jul 20, 2009 by a Female patient taking Metformin (View Usage) (Dosage: 500 Mg, Unk) was diagnosed with glucose tolerance impaired, lower respiratory tract infection, hypertension and. Location: UNITED KINGDOM , 61 years of age, weighting 176.4 lb, Patient had the following side effects: hepatitis acute. During the same period patient was treated with AMOXICILLIN (50 Mg, Unk) (View Amoxicillin Review and Amoxicillin Label ), COZAAR (50 Mg, Unk) (View Cozaar Review and Cozaar Label ).

6288626-4 | Hepatitis Acute
on Jul 20, 2009 Female patient from UNITED KINGDOM , 61 years of age, weighting 176.4 lb, was diagnosed with glucose tolerance impaired and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: hepatitis acute. Metformin dosage: .

6287005-3 | Epstein-barr Virus Antibody Positive, Hodgkin's Disease, Onychomycosis, Pyrexia, Tooth Abscess, Weight Increased
on Jul 14, 2009 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with diabetes mellitus, blood cholesterol increased, analgesia, psoriatic arthropathy, fungal infection (What is fungal infection?), erectile dysfunction (What is erectile dysfunction?) and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: epstein-barr virus antibody positive, hodgkin's disease (What is hodgkin's disease?), onychomycosis, pyrexia, tooth abscess, weight increased. Metformin dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), HUMIRA (View Humira Review and Humira Label ), LAMISIL (View Lamisil Review and Lamisil Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ).

6286931-9 | Asterixis, Dysarthria, Gait Disturbance, Haemodialysis, Hemiparesis, Myoclonus, Toxic Encephalopathy, Trismus
Patient was taking Metformin (View Usage). Patient had the following side effects: asterixis, dysarthria, gait disturbance, haemodialysis, hemiparesis, myoclonus, toxic encephalopathy, trismus on Jul 09, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 51 years of age, . Metformin dosage: 850mg, Daily. During the same period patient was treated with REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INSULIN (View Insulin Review and Insulin Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ). Patient was hospitalized.

6278713-9 | Dehydration, Hypoglycaemia, Lactic Acidosis, Renal Failure Acute, Shock
Adverse event was reported on Jul 09, 2009 by a Female patient taking Metformin (View Usage) (Dosage: 850mg, Tid,oral) . Location: UNITED STATES , 61 years of age, After Metformin was administered, patient had the following side effects: dehydration, hypoglycaemia, lactic acidosis, renal failure acute, shock. During the same period patient was treated with GLICLAZIDE (900mg,daily,oral) (View Gliclazide Review and Gliclazide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), QUINAPRIL (View Quinapril Review and Quinapril Label ). Patient was hospitalized.

6278712-7 | Dehydration, Lactic Acidosis, Renal Failure Acute
on Jul 09, 2009 Female patient from UNITED STATES , 68 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, lactic acidosis, renal failure acute. Metformin dosage: 3g, Oral. During the same period patient was treated with GLIBENCLAMIDE (20mg, Oral) (View Glibenclamide Review and Glibenclamide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LANTUS (View Lantus Review and Lantus Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), TELMISARTAN/HYDROCHLOROTHIAZIDE (View Telmisartan/hydrochlorothiazide Review and Telmisartan/hydrochlorothiazide Label ), GLUCOSAMINE HYDROCHLORIDE (View Glucosamine Hydrochloride Review and Glucosamine Hydrochloride Label ), SALMETEROL XINAFOATE/FLUTICASONE PROPIONATE (View Salmeterol Xinafoate/fluticasone Propionate Review and Salmeterol Xinafoate/fluticasone Propionate Label ). Patient was hospitalized.

6132769-2 | Liver Function Test Abnormal, Vomiting
on Mar 18, 2009 Male patient from UNITED KINGDOM , 45 years of age, weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient had the following side effects: liver function test abnormal, vomiting. Metformin dosage: . During the same period patient was treated with VILDAGLIPTIN (View Vildagliptin Review and Vildagliptin Label ).

6132765-5 | Erythema, Hypertension, Loss Of Consciousness
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: erythema, hypertension, loss of consciousness on Mar 20, 2009 from ITALY Additional patient health information: Male patient , 39 years of age, . Metformin dosage: . During the same period patient was treated with FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ). Patient was hospitalized.

6130580-X | Diarrhoea, Hypotension, Lactic Acidosis, Renal Failure Acute, Vomiting
Adverse event was reported on Mar 17, 2009 by a Female patient taking Metformin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED KINGDOM , 58 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, hypotension, lactic acidosis, renal failure acute, vomiting. Patient was hospitalized.

6122288-1 | Cardiac Arrest, Diarrhoea, Haemodialysis, Hypotension, Lactic Acidosis, Renal Failure Acute
on Mar 02, 2009 Female patient from , 63 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), diarrhoea, haemodialysis, hypotension, lactic acidosis, renal failure acute. Metformin dosage: Oral. Patient was hospitalized.

6106247-0 | Hallucination, Visual
on Feb 27, 2009 Male patient from UNITED KINGDOM , 72 years of age, weighting 174.2 lb, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: hallucination, visual. Metformin dosage: .

6106235-4 | Haemolytic Anaemia, Haemolytic Uraemic Syndrome, Renal Failure Acute, Thrombocytopenia
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, haemolytic uraemic syndrome, renal failure acute, thrombocytopenia on Feb 27, 2009 from SWITZERLAND Additional patient health information: Female patient , 55 years of age, was diagnosed with type 1 diabetes mellitus, depression (What is depression?) and. Metformin dosage: . During the same period patient was treated with JANUMET (View Janumet Review and Janumet Label ), JANUVIA (View Januvia Review and Januvia Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), CALCIUM CARBONATE W/COLECALCIFEROL (View Calcium Carbonate W/colecalciferol Review and Calcium Carbonate W/colecalciferol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6106231-7 | Hepatocellular Injury, Jaundice
Adverse event was reported on Feb 27, 2009 by a Male patient taking Metformin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, myelodysplastic syndrome, mineral supplementation and. Location: SWITZERLAND , 50 years of age, Patient had the following side effects: hepatocellular injury, jaundice (What is jaundice?). During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), EXJADE (View Exjade Review and Exjade Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6102875-7 | Hallucination, Visual
on Feb 25, 2009 Male patient from UNITED KINGDOM , 72 years of age, weighting 174.2 lb, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: hallucination, visual. Metformin dosage: 500 Mg, Qd.

6090950-5 | Blood Albumin Increased, Blood Bicarbonate Decreased, Blood Pressure Decreased, Bradycardia, Coma, Convulsion, Depressed Level Of Consciousness, Endotracheal Intubation, Extubation
on Feb 18, 2009 Female patient from UNITED KINGDOM , 14 years of age, weighting 88.18 lb, was diagnosed with incorrect dose administered and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin increased, blood bicarbonate decreased, blood pressure decreased, bradycardia, coma, convulsion, depressed level of consciousness, endotracheal intubation, extubation. Metformin dosage: 500 Mg, 126 Tablets. During the same period patient was treated with DICLOFENAC (75 Mg, 14 Tablets) (View Diclofenac Review and Diclofenac Label ), ATENOLOL (50 Mg, 28 Tablets) (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6089127-9 | Thrombotic Thrombocytopenic Purpura
Patient was taking Metformin (View Usage). Patient had the following side effects: thrombotic thrombocytopenic purpura on Feb 09, 2009 from GERMANY Additional patient health information: Male patient , weighting 202.8 lb, was diagnosed with type 2 diabetes mellitus, hypertension, pain (What is pain?), back pain (What is back pain?) and. Metformin dosage: . During the same period patient was treated with CAPTOPRIL PLUS (25/12.5mg) (View Captopril Plus Review and Captopril Plus Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ). Patient was hospitalized.

6056123-7 | Completed Suicide
Adverse event was reported on Jan 16, 2009 by a Male patient taking Metformin (View Usage) (Dosage: ) was diagnosed with completed suicide and. Location: UNITED STATES , 76 years of age, After Metformin was administered, patient had the following side effects: completed suicide. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), LEVODOPA (View Levodopa Review and Levodopa Label ).

6036118-X |
on Jan 07, 2009 Female patient from UNITED KINGDOM , 36 years of age, weighting 143.3 lb, was diagnosed with gestational diabetes and was treated with Metformin (View Usage). . Metformin dosage: .

6036117-8 | Foetal Growth Retardation, Oesophageal Atresia, Tracheo-oesophageal Fistula
on Jan 07, 2009 Female patient from UNITED KINGDOM , weighting 114.6 lb, was treated with Metformin (View Usage). Patient had the following side effects: foetal growth retardation, oesophageal atresia, tracheo-oesophageal fistula. Metformin dosage: .

5912931-1 | Agitation, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Cardiac Arrest, Haemolytic Anaemia, Heart Rate Increased, Hyperkalaemia, Hypotension
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), cardiac arrest (What is cardiac arrest?), haemolytic anaemia, heart rate increased, hyperkalaemia, hypotension on Sep 22, 2008 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with type 2 diabetes mellitus and. Metformin dosage: 500 Mg; Twice A Day. During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

5878347-1 | Hypersensitivity
Adverse event was reported on Sep 02, 2008 by a Female patient taking Metformin (View Usage) (Dosage: Unk) was diagnosed with stent placement, coronary artery disease (What is coronary artery disease?) and. Location: POLAND , 70 years of age, Patient experienced the following unwanted or unexpected effects: hypersensitivity. During the same period patient was treated with ATORVASTATIN CALCIUM (Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), INDAPAMIDE (Unk) (View Indapamide Review and Indapamide Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

5811138-6 | Holoprosencephaly
on Jul 09, 2008 Female patient from UNITED KINGDOM , 39 years of age, was diagnosed with infertility (What is infertility?) and was treated with Metformin (View Usage). Patient had the following side effects: holoprosencephaly. Metformin dosage: .

5807942-0 | Completed Suicide
on Jan 25, 2008 Female patient from UNITED STATES , 37 years of age, was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: completed suicide. Metformin dosage: Route: Ingestion.. During the same period patient was treated with DIAZEPAM (Route: Ingestion.) (View Diazepam Review and Diazepam Label ), HYPOGLYCEMICS NOS (Route: Ingestion.) (View Hypoglycemics Nos Review and Hypoglycemics Nos Label ), VENLAFAXINE HCL (Route: Ingestion.) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (Reported As Hydrocodone/acetaminophen. Route: Ingestion.) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), GLIPIZIDE (Route: Ingestion.) (View Glipizide Review and Glipizide Label ), GABAPENTIN (Route: Ingestion.) (View Gabapentin Review and Gabapentin Label ), RAMIPRIL (Route: Ingestion.) (View Ramipril Review and Ramipril Label ), ANTIHISTAMINE/DECONGESTANT (Route: Ingestion.) (View Antihistamine/decongestant Review and Antihistamine/decongestant Label ).

5807367-8 | Urticaria
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria on Jul 04, 2008 from NORWAY Additional patient health information: Female patient , weighting 169.8 lb, was diagnosed with type 2 diabetes mellitus and. Metformin dosage: . Patient was hospitalized.

5805786-7 | Autoimmune Neutropenia
Adverse event was reported on Jul 07, 2008 by a Male patient taking Metformin (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: FRANCE , 75 years of age, Patient had the following side effects: autoimmune neutropenia. Patient was hospitalized.

5780540-3 | Hypersensitivity
on Jun 10, 2008 Female patient from POLAND , 70 years of age, was diagnosed with stent placement and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: hypersensitivity. Metformin dosage: Unk. During the same period patient was treated with ATORVASTATIN (Unk) (View Atorvastatin Review and Atorvastatin Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), INDAPAMIDE (Unk) (View Indapamide Review and Indapamide Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (300 Mg Loading Dose Follwed By 75 Mg Daily) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5504021-7 | Electrocardiogram Change, Hyperkalaemia
on Jul 20, 2007 Female patient from UNITED KINGDOM , 58 years of age, was diagnosed with diabetes mellitus, blood pressure (What is blood pressure?), fluid retention, polymyalgia rheumatica (What is polymyalgia rheumatica?), hypothyroidism and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram change, hyperkalaemia. Metformin dosage: . During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5484139-8 | Jaundice, Metabolic Acidosis, Sepsis
Patient was taking Metformin (View Usage). Patient had the following side effects: jaundice (What is jaundice?), metabolic acidosis, sepsis (What is sepsis?) on Oct 09, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 246.9 lb, was diagnosed with diabetes mellitus and. Metformin dosage: 1000 Mg Q Am Po 500 Mg Q Pm Po.